Literature DB >> 21192240

Risk of decline in functional activities in dementia with Lewy bodies and Alzheimer disease.

Dawn P Gill1, Thomas D Koepsell, Rebecca A Hubbard, Walter A Kukull.   

Abstract

We examined the risk of 1-year decline in 4 everyday activities in patients with dementia with Lewy bodies (DLB), relative to patients with Alzheimer disease (AD). Data were from the National Alzheimer's Coordinating Center, gathered from 32 Alzheimer's Disease Centers. Participants (n=1880) were: aged 60+ years, demented with a primary clinical diagnosis of probable AD or DLB, and had a global Clinical Dementia Rating of 0.5 to 2. The activities were measured with the Functional Activities Questionnaire. In modified Poisson regression models adjusted for demographics, baseline activity, years from symptom onset, cognitive impairment, and comorbidities; DLB participants aged 67 to 81 years had 1.5 to 2 times increased risk of decline in performing basic kitchen tasks, engaging in games/hobbies, and paying attention/understanding, relative to AD participants of the same age (P<0.05). There was no significant difference between AD and DLB participants beyond this age range. For decline in ability to go shopping alone, there was also no significant difference between AD and DLB participants. In summary, the functional course of DLB, relative to AD, may depend on the age of the patient. These findings may provide anticipatory guidance to families and healthcare providers, which may be useful in the planning of care strategies.
Copyright © 2011 by Lippincott Williams & Wilkins

Entities:  

Mesh:

Year:  2011        PMID: 21192240      PMCID: PMC3053143          DOI: 10.1097/WAD.0b013e3182037edf

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN: 0893-0341            Impact factor:   2.703


  29 in total

1.  Verbal and visuospatial deficits in dementia with Lewy bodies.

Authors:  David K Johnson; John C Morris; James E Galvin
Journal:  Neurology       Date:  2005-10-25       Impact factor: 9.910

2.  The progression of cognition, psychiatric symptoms, and functional abilities in dementia with Lewy bodies and Alzheimer disease.

Authors:  Karina Stavitsky; Adam M Brickman; Nikolaos Scarmeas; Rebecca L Torgan; Ming-Xin Tang; Marilyn Albert; Jason Brandt; Deborah Blacker; Yaakov Stern
Journal:  Arch Neurol       Date:  2006-10

3.  The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers.

Authors:  John C Morris; Sandra Weintraub; Helena C Chui; Jeffrey Cummings; Charles Decarli; Steven Ferris; Norman L Foster; Douglas Galasko; Neill Graff-Radford; Elaine R Peskind; Duane Beekly; Erin M Ramos; Walter A Kukull
Journal:  Alzheimer Dis Assoc Disord       Date:  2006 Oct-Dec       Impact factor: 2.703

4.  Survival and mortality differences between dementia with Lewy bodies vs Alzheimer disease.

Authors:  Monique M Williams; Chengjie Xiong; John C Morris; James E Galvin
Journal:  Neurology       Date:  2006-12-12       Impact factor: 9.910

5.  Cognitive decline is faster in Lewy body variant than in Alzheimer's disease.

Authors:  J M Olichney; D Galasko; D P Salmon; C R Hofstetter; L A Hansen; R Katzman; L J Thal
Journal:  Neurology       Date:  1998-08       Impact factor: 9.910

6.  Assessment of progression and prognosis in 'possible' and 'probable' Alzheimer's disease.

Authors:  G R Swanwick; R F Coen; D Coakley; B A Lawlor
Journal:  Int J Geriatr Psychiatry       Date:  1998-05       Impact factor: 3.485

7.  Personality traits distinguishing dementia with Lewy bodies from Alzheimer disease.

Authors:  James E Galvin; Heather Malcom; David Johnson; John C Morris
Journal:  Neurology       Date:  2007-05-29       Impact factor: 9.910

8.  Patients with dementia with lewy bodies have more impaired quality of life than patients with Alzheimer disease.

Authors:  Fredrik Boström; Linus Jönsson; Lennart Minthon; Elisabet Londos
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Apr-Jun       Impact factor: 2.703

9.  More severe functional impairment in dementia with lewy bodies than Alzheimer disease is related to extrapyramidal motor dysfunction.

Authors:  Ian G McKeith; Elise Rowan; Kristina Askew; Anitha Naidu; Louise Allan; Nicky Barnett; Debbie Lett; Urs P Mosimann; David Burn; John T O'Brien
Journal:  Am J Geriatr Psychiatry       Date:  2006-07       Impact factor: 4.105

Review 10.  Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Authors:  I G McKeith; D W Dickson; J Lowe; M Emre; J T O'Brien; H Feldman; J Cummings; J E Duda; C Lippa; E K Perry; D Aarsland; H Arai; C G Ballard; B Boeve; D J Burn; D Costa; T Del Ser; B Dubois; D Galasko; S Gauthier; C G Goetz; E Gomez-Tortosa; G Halliday; L A Hansen; J Hardy; T Iwatsubo; R N Kalaria; D Kaufer; R A Kenny; A Korczyn; K Kosaka; V M Y Lee; A Lees; I Litvan; E Londos; O L Lopez; S Minoshima; Y Mizuno; J A Molina; E B Mukaetova-Ladinska; F Pasquier; R H Perry; J B Schulz; J Q Trojanowski; M Yamada
Journal:  Neurology       Date:  2005-10-19       Impact factor: 9.910

View more
  4 in total

1.  Associations among Braak stage, Parkinsonian gait, cognition, and functional status in autopsy-confirmed dementia with Lewy bodies.

Authors:  Ann M Mayo; Guerry M Peavy
Journal:  Int J Geriatr Psychiatry       Date:  2019-03-15       Impact factor: 3.485

2.  Predictors of Mortality in Individuals with Dementia in the National Alzheimer's Coordinating Center.

Authors:  Melissa J Armstrong; Shangchen Song; Andrea M Kurasz; Zhigang Li
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

3.  Differences in rate of functional decline across three dementia types.

Authors:  Dawn P Gill; Rebecca A Hubbard; Thomas D Koepsell; Michael J Borrie; Robert J Petrella; David S Knopman; Walter A Kukull
Journal:  Alzheimers Dement       Date:  2013-05-02       Impact factor: 21.566

Review 4.  Exercise for Individuals with Lewy Body Dementia: A Systematic Review.

Authors:  Michael Inskip; Yorgi Mavros; Perminder S Sachdev; Maria A Fiatarone Singh
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.